CompaniesPeople
Riskgaming
Missioncontact
Read & Listen
Articles & Episodes
Stay informed with our expert insights and updates from our team
Play
Scenarios
Immerse in challenging situations tackling real-world problems
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
suggestions
Transportation
Artificial Intelligence
Companies
“Securities”
news
People
 
A-Alpha Bio
“securities”
This is some text inside of a div block.
About
Companies
People
Mission
riskgaming
Articles & Episodes
Scenarios
More
Events
Press
Brand kit
contact us
cerulean-pharma-cover-image

Using the science of nanotechnology, Cerulean is developing a suite of potent new cancer drugs that selectively target tumors, burrowing their way into cancer cells while leaving healthy cells unaffected. Clinical results indicate the drugs have the potential to be effective across numerous cancer types, while improving both safety and quality-of-life for patients. The company’s lead drug is currently being evaluated in Phase II clinical trials. The drug platform has also shown promise in delivering gene therapy to cancer cells. The company completed its IPO in 2014.

Nulla adipisicing do ut aliquip elit tempor fugiat. Mollit est exercitation excepteur ea consequat ullamco Lorem ex id. Ipsum nostrud Lorem dolor nisi do est in ex amet eu nostrud. Amet commodo consectetur enim nostrud dolore sint excepteur irure aliqua consectetur. Veniam occaecat et enim eiusmod qui fugiat eiusmod eiusmod laborum exercitation veniam ipsum velit. Ut veniam cupidatat ea tempor ad ad exercitation amet qui. Esse commodo sint deserunt ut elit minim sint. Amet laborum ut adipisicing minim sunt cillum anim in est ipsum aliquip anim in tempor pariatur.

‍

industries

Biology Biochemistry

Advancing Human Health

Milestones

Lux investment: 2007

IPO (NASDAQ: CERU): 2014

Founders

Alan Crane

Ram Sasisekharan

Shiladitya Sengupta

Lux partners
No items found.
Open Positions
Visit Website

Cerulean Pharma

Similar companies

eikon-therapeutics-cover-image
Eikon Therapeutics
Biology + Biochemistry
Advancing Human Health
Progressing Science + Knowledge
2
josh-wolfe

Eikon Therapeutics is pioneering a new method of drug discovery based on tracking and measuring the movement of individual proteins in living cells.

industries

Biology Biochemistry

Advancing Human Health

Progressing Science Knowledge

Milestones

Lux investment: 2019

Founders

Eric Betzig

Robert Tjian

Luke Lavis

Xavier Darzacq

Lux partners
view company profile
{name}
{name}
kallyope-cover-image
Kallyope
Biology + Biochemistry
Advancing Human Health
5
josh-wolfe

Kallyope is a platform biotechnology company dedicated to unlocking the therapeutic and nutritional product potential of the gut-brain axis.

industries

Biology Biochemistry

Advancing Human Health

Milestones

Lux founded: 2015

Founders

Richard Axel

Tom Maniatis

Charles Zuker

Nancy Thornberry

Lux partners
view company profile
{name}
{name}
benchling-cover-image
Benchling
Advancing Human Health
Progressing Science + Knowledge
10
brandon-reeves

Benchling is transforming research and development with the industry's most widely adopted Life Sciences R&D Cloud.

industries

Advancing Human Health

Progressing Science Knowledge

Milestones

Lux investment: 2020

Founders

Saji Wickramasekara

Ashu Singhal

Lux partners
view company profile
{name}
{name}
recursion-pharma-cover-image
Recursion Pharma
Biology + Biochemistry
Advancing Human Health
Progressing Science + Knowledge
16

Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets. The company completed its IPO [NASDAQ: RXRX] in 2021.

industries

Biology Biochemistry

Advancing Human Health

Progressing Science Knowledge

Milestones

Lux investment: 2016

IPO: 2021

Founders

Chris Gibson, PhD

Blake Borgeson, PhD

Dean Li, PhD

Lux partners
view company profile
{name}
{name}
maven-cover-image
Maven
Advancing Human Health
17
deena-shakir

Maven is the largest virtual clinic for women's and family health.

industries

Advancing Human Health

Milestones

Lux investment: 2021

Founders
Lux partners
view company profile
{name}
{name}
auris-health-cover-image
Auris Health
Engineering + Electronics
Advancing Human Health
Increasing Productivity + Efficiency
18
peter-hebert

Auris Healthis an ambitious robotics company based in Silicon Valley. Auris was acquired for up to $6.1B by Johnson & Johnson in 2019.

industries

Engineering Electronics

Advancing Human Health

Increasing Productivity Efficiency

Milestones

Lux investment: 2012

Acquired by JNJ: 2019

Founders

Fred Moll

Lux partners
view company profile
{name}
{name}
evolutionaryscale-cover-image
Evolutionary Scale
Biology + Biochemistry
Progressing Science + Knowledge
21
josh-wolfe

ESM3 is the first generative AI model for biology that simultaneously reasons over the sequence, structure, and function of proteins. This enables scientists to understand and create new proteins, making biology programmable.

industries

Biology Biochemistry

Milestones

Lux investment: 2023

Founders

Alex Rives

Tom Sercu

Sal Candido

Lux partners
view company profile
{name}
{name}
cajal-neuroscience-cover-image
Cajal Neuroscience
Biology + Biochemistry
Advancing Human Health
Progressing Science + Knowledge
24
josh-wolfe,ian-peikon

Cajal Neuroscienceis a drug discovery company focused on neurodegenerative disease.

industries

Biology Biochemistry

Advancing Human Health

Progressing Science Knowledge

Milestones

Lux investment: 2020

Founders

Ian Peikon, PhD

Charles Zuker, PhD

Huda Zoghbi, MD

Tony Zador, MD, PhD

Rob Hershberg, MD, PhD

Andrew Dervan, MD

Lux partners
view company profile
{name}
{name}
We believe before others understand
New York
920 Broadway 11th Floor
New York, NY 10010
[P]
646.475.4385
[F]
646.349.2960
Silicon VAlley
1600 El Camino Real, Ste 290
Menlo Park, CA 94025
[P]
646.475.4385
[F]
646.349.2960
Media
Events
Brand assets
[E]
comms@luxcapital.com
[E]
info@luxcapital.com
© 2024 Lux Capital. All Rights REserved.
Privacy & Terms
David Yang
Kim Tran
Tess van Stekelenburg
Andrew Wilson
Tracie Rotter
Stevie Lee
Steven Brody
Shaq Vayda
Shahin Farshchi, PhD
Segolene Scarborough
Sean Traynor
Scott Rubin
Saunaz Moradi
Samuel Arbesman, PhD
Samantha Cho
Peter Hébert
Lindsay Morris
Lan Jiang
Josh Wolfe
Grace Isford
Deena Shakir
Debbie Elsen
Danny Crichton
Cristina Morris
Bree Morgan
Brandon Reeves
Brad Gritsch
Bilal Zuberi
Bibi Masara
Alex Nguyen
Adam Kalish